Erste Asset Management Gmb H Moon Lake Immunotherapeutics Transaction History
Erste Asset Management Gmb H
- $8.35 Trillion
- Q3 2024
A detailed history of Erste Asset Management Gmb H transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Erste Asset Management Gmb H holds 15,000 shares of MLTX stock, worth $775,650. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$775,650% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
123Shares Held
58.2MCall Options Held
52.2KPut Options Held
31.9K-
Bvf Inc San Francisco, CA21.8MShares$1.12 Billion34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$439 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$154 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$143 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$120 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.91B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...